Randomized double blind placebo controlled phase 3 study of Itacitinib or placebo in combination with corticosteroids for the treatment of first line acute graft versus host disease
This study is evaluating the efficacy of an experimental drug in combination with corticosteroids in bone marrow transplant patients with acute graft versus host disease.
Those eligible to participate in this study include:
Interactive Campus Map
2500 North State Street
Jackson, MS 39216
General Information: 601-984-1000
Patient Appointments: 888-815-2005